[1] Ma YJ, He M,Han JA, et al. A Clinical Study of HBsAg-Activated Dendritic Cells and Cytokine-Induced Killer Cells During the Treatment for Chronic Hepatitis B. Scandinavian Immunology,2013,78:387-393.
[2] Balmasova IP,Yashohuk ND, Mgnbaev OA, et al. Immunopatho-genesis of chronic hepatitis B. World J Gastroenterol,2014,20:14156-14171.
[3] Sakaki M,Hiroishi K,Baba T,et al. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol Res,2008,38:354-361.
[4] 李鸿宾,江晓萍,叶珺,等. 测定慢性乙型肝炎患者外周血T淋巴细胞亚群的临床意义. 安徽医药,2006, 10:588-589.
[5] 中华医学会肝病学分会、中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015更新版). 肝脏,2015,20:915-932.
[6] 李萍,史茜,王波,等. 多项生化指标在常见肝病诊断中的价值.国际检验医学杂志,2013,34:3205-3207.
[7] 彭健新. 8项生化指标在常见肝病中的诊断意义及相关分析. 中国当代医药,2011,18:77-78.
[8] 王健,李朝品. HBV感染乙肝患者PBMC后对细胞免疫功能的影响. 中国人兽共患病杂志,1998,14:90-92.
[9] 中华医学会传染病与寄生虫病学分会、中华医学会肝病学分会. 病毒性肝炎的诊断标准.中西医结合肝病杂志,2001,11:56-60.
[10] 姚光弼,王宝恩,崔振宇,等. 拉米夫定治疗慢性乙型肝炎病人的长期疗效. 中华肝脏病杂志,1999,7:80-83.
[11] 朱春兰,干迪郁,伍华东,等. 慢性乙型肝炎患者外周血 CD8+淋巴细胞上CD28抗原的表达. 放射免疫学杂志,2013,26:238-239.
[12] Franzese O, Kenndy PT, Gehring AJ, et al. Modulation of the CD8+T cell response by CD4+CD25+ regulatory cells in patients with hepatitis B virus infection. Viral,2005,79:3322-3328.
[13] Akbar SM,Furukawa S,Horiike N,et al. Safety and immunogenicity of hepatitis B surface antigen-pulse dendritic cells in patents with chronic hepatitis B. J Viral Hepat,2011,18:408-414. |
